Page last updated: 2024-11-12

glycyl-prolyl-hydroxyproline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glycyl-prolyl-hydroxyproline: the main component of the mixture of collagen type I degradation products [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11778669
CHEBI ID193240
SCHEMBL ID3942552
MeSH IDM0233417

Synonyms (18)

Synonym
glycylprolylhydroxyproline
(2s,4r)-1-[(2s)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carboxylic acid
2239-67-0
CHEBI:193240
SCHEMBL3942552
glycyl-prolyl-hydroxyproline
h-gly-pro-hyp-oh
(2s,4r)-1-((s)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid
mfcd00037343
SZEOBSAZWJLOGY-VGMNWLOBSA-N
tripeptide 29
l-proline, glycyl-l-prolyl-4-hydroxy-, (4r)-
X6346H6PUM ,
(2s,4r)-1-(((2s)-1-(aminoacetyl)-2-pyrrolidinyl)carbonyl)-4-hydroxy-2-pyrrolidinecarboxylic acid
tripeptide-29
unii-x6346h6pum
DTXSID801311276
h-gly-pro-hyp-oh (acetate)

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" To increase the bioavailability of bioactive peptides, a collagen tripeptide (CTP) was prepared from fish scales by the digestion method using collagenase from nonpathogenic Bacillus bacteria."( Orally Available Collagen Tripeptide: Enzymatic Stability, Intestinal Permeability, and Absorption of Gly-Pro-Hyp and Pro-Hyp.
Chung, HJ; Jung, JH; Piao, Z; Sontakke, SB, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oligopeptideA peptide containing a relatively small number of amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.55)18.7374
1990's6 (27.27)18.2507
2000's3 (13.64)29.6817
2010's9 (40.91)24.3611
2020's3 (13.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.04 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (17.39%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (82.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]